Table 3.
Outcomes: | ACT | CBT |
Between Groups |
ACT | CBT | |
---|---|---|---|---|---|---|
Anxiety Specific | ||||||
CSR | ||||||
Linear Pre-Post | −3.74 | −3.46 | 0.26 | Quadratic: β | 0.71 | 0.73 |
Linear Post-FU | −1.98 | −1.78 | 0.32 | Quadratic: effect size (d) | 0.82 | 0.84 |
Linear 6–12m FU | −0.46 | −0.08 | 0.38 | |||
ASI | ||||||
Linear Pre-Post | −1.18 | −0.63 | 0.55 | Quadratic: β | 3.08 | 1.39 |
Linear Post-FU | −0.65 | −0.39 | 0.26 | Quadratic: effect size (d) | 0.26 | 0.12 |
Linear 6–12m FU | −0.12 | −0.15 | 0.03 | |||
PSWQ | ||||||
Linear Pre-Post | −0.74 | −0.64 | 0.11 | Quadratic: β | 2.00 | 1.64 |
Linear Post-FU | −0.40 | −0.36 | 0.05 | Quadratic: effect size (d) | 0.17 | 0.14 |
Linear 6–12m FU | −0.06 | −0.07 | 0.02 | |||
FQ | ||||||
Linear Pre-Post | −0.83 | −0.52 | 0.31 | Quadratic: β | 0.34 | 0.61 |
Linear Post-FU | −0.38 | −0.27 | 0.11 | Quadratic: effect size (d) | 0.13 | 0.22 |
Linear 6–12m FU | 0.06 | −0.02 | 0.08 | |||
Non-Anxiety Specific | ||||||
AAQ (higher scores indicate improvement) | ||||||
Linear Pre-Post | 1.16 | 0.90 | 0.26 | Quadratic: β | −3.20 | −2.70 |
Linear Post-FU | 0.63 | 0.45 | 0.18 | Quadratic: effect size (d) | −0.27 | −0.22 |
Linear 6–12m FU | 0.10 | 0.00 | 0.10 | |||
QOLI (higher scores indicate improvement) | ||||||
Linear Pre-Post | 0.43 | 0.43 | 0.00 | Quadratic: β | −0.15 | −0.21 |
Linear Post-FU | 0.21 | 0.26 | 0.06 | Quadratic: effect size (d) | −0.08 | −0.11 |
Linear 6–12m FU | 0.00 | 0.12 | 0.12 |
Notes: For the sake of clarity, effect sizes reflect HLM models with linear and quadratic time terms only. Quadratic terms are invariant across assessment points.
CSR = ADIS-IV principal disorder clinical severity ratings; ASI = Anxiety Sensitivity Index; PSWQ = Penn State Worry Questionnaire; FQ = Main Target Phobia Scale (behavioral avoidance rating) from the Fear Questionnaire; AAQ = Acceptance and Action Questionnaire; QOLI = Quality of Life Inventory